Activation of toll-like receptor 3 protects against DSS-induced acute colitis - PubMed (original) (raw)
Activation of toll-like receptor 3 protects against DSS-induced acute colitis
Matam Vijay-Kumar et al. Inflamm Bowel Dis. 2007 Jul.
Abstract
Background: Mimetics of bacterial DNA, given orally or subcutaneously, protect mice from experimental colitis via a toll-like receptor (TLR)-9-dependent mechanism. The goal of the study was to define whether synthetic viral RNA, polyinosinic acid:cytidylic acid [poly(I:C)], which is also a potent immunomodulator, might also affect murine colitis and, if so, define whether such effects were mediated by TLR3, which is one of at least 4 known receptors for this viral RNA analog.
Methods: Mice (C57BL6, IL-10KO, or TLR3 KO) were administered 1.5% dextran sodium sulfate (DSS) in drinking water for 7 days. Two hours before treatment with DSS, mice were given phosphate-buffered saline (PBS) or poly(I:C) 20 mug subcutaneously (s.c.), or 100 mug intragastrically (i.g.).
Results: In wildtype mice s.c. administration of poly(I:C) dramatically protected against DSS-induced colitis as assessed by every parameter analyzed, which included body weight, rectal bleeding, colonic myeloperoxidase, histopathology, serum keratinocyte-derived chemokine, serum amyloid A, and lipocalin-2. In contrast, i.g. administration of poly(I:C) offered no protection in this colitis model nor did its administration activate the innate immune system as assessed by serologic parameters. Subcutaneous poly(I:C) protected against DSS-induced colitis equally well in C57BL6 and IL-10KO mice, indicating that this antiinflammatory cytokine is not required for such protection. Protection against colitis given by poly(I:C) treatment was ablated in TLR3 KO, indicating that the protective action of this viral RNA analog was mediated by this receptor.
Conclusions: Activation of TLR3 on cells that are accessible by systemic, but not oral, administration of synthetic viral RNA results in protection against the acute inflammation that can ensue upon damage of the gut epithelium. Thus, this viral RNA analog, which is under clinical trials for other inflammatory disorders (e.g., lupus), may also have therapeutic value for inflammatory bowel disease.
Similar articles
- Effect of toll-like receptor 3 agonist poly I:C on intestinal mucosa and epithelial barrier function in mouse models of acute colitis.
Zhao HW, Yue YH, Han H, Chen XL, Lu YG, Zheng JM, Hou HT, Lang XM, He LL, Hu QL, Dun ZQ. Zhao HW, et al. World J Gastroenterol. 2017 Feb 14;23(6):999-1009. doi: 10.3748/wjg.v23.i6.999. World J Gastroenterol. 2017. PMID: 28246473 Free PMC article. - Toll-like receptor 3 pre-conditioning increases the therapeutic efficacy of umbilical cord mesenchymal stromal cells in a dextran sulfate sodium-induced colitis model.
Fuenzalida P, Kurte M, Fernández-O'ryan C, Ibañez C, Gauthier-Abeliuk M, Vega-Letter AM, Gonzalez P, Irarrázabal C, Quezada N, Figueroa F, Carrión F. Fuenzalida P, et al. Cytotherapy. 2016 May;18(5):630-41. doi: 10.1016/j.jcyt.2016.02.002. Cytotherapy. 2016. PMID: 27059200 - Toll-Like Receptor 7 Agonist-Induced Dermatitis Causes Severe Dextran Sulfate Sodium Colitis by Altering the Gut Microbiome and Immune Cells.
Kiyohara H, Sujino T, Teratani T, Miyamoto K, Arai MM, Nomura E, Harada Y, Aoki R, Koda Y, Mikami Y, Mizuno S, Naganuma M, Hisamatsu T, Kanai T. Kiyohara H, et al. Cell Mol Gastroenterol Hepatol. 2018 Sep 25;7(1):135-156. doi: 10.1016/j.jcmgh.2018.09.010. eCollection 2019. Cell Mol Gastroenterol Hepatol. 2018. PMID: 30510995 Free PMC article. - Toll-like receptor-7 ligand Imiquimod induces type I interferon and antimicrobial peptides to ameliorate dextran sodium sulfate-induced acute colitis.
Sainathan SK, Bishnupuri KS, Aden K, Luo Q, Houchen CW, Anant S, Dieckgraefe BK. Sainathan SK, et al. Inflamm Bowel Dis. 2012 May;18(5):955-67. doi: 10.1002/ibd.21867. Epub 2011 Sep 26. Inflamm Bowel Dis. 2012. PMID: 21953855 Free PMC article. - Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein.
Foligne B, Dessein R, Marceau M, Poiret S, Chamaillard M, Pot B, Simonet M, Daniel C. Foligne B, et al. Gastroenterology. 2007 Sep;133(3):862-74. doi: 10.1053/j.gastro.2007.06.018. Epub 2007 Jun 20. Gastroenterology. 2007. PMID: 17678918
Cited by
- Toll-like receptor 3 signaling drives enteric glial cells against dextran sulfate sodium-induced colitis in mice.
Zeng J, Lu QQ, Du XL, Yuan L, Yang XJ. Zeng J, et al. J Mol Histol. 2024 Apr;55(2):201-210. doi: 10.1007/s10735-024-10184-7. Epub 2024 Feb 20. J Mol Histol. 2024. PMID: 38376631 - Contribution of Blood Vessel Activation, Remodeling and Barrier Function to Inflammatory Bowel Diseases.
Britzen-Laurent N, Weidinger C, Stürzl M. Britzen-Laurent N, et al. Int J Mol Sci. 2023 Mar 14;24(6):5517. doi: 10.3390/ijms24065517. Int J Mol Sci. 2023. PMID: 36982601 Free PMC article. Review. - Ten things to know about NLRP10.
Masters SL. Masters SL. Nat Immunol. 2023 Apr;24(4):561-562. doi: 10.1038/s41590-023-01466-5. Nat Immunol. 2023. PMID: 36949288 No abstract available. - Anti-E. coli Immunoglobulin Yolk (IgY): Reduction of pathogen receptors and inflammation factors could be caused by decrease in E. coli load.
Bouazzaoui A, Bogari NM, Al-Allaf FA, Ekram SN, Athar M, Dannoun A, Schubert T, Syed SN, Youssef AR, Alqahtani M, Abdellatif AAH. Bouazzaoui A, et al. Heliyon. 2023 Feb 21;9(3):e13876. doi: 10.1016/j.heliyon.2023.e13876. eCollection 2023 Mar. Heliyon. 2023. PMID: 36873547 Free PMC article. - Host-pathogen protein-nucleic acid interactions: A comprehensive review.
Jain A, Mittal S, Tripathi LP, Nussinov R, Ahmad S. Jain A, et al. Comput Struct Biotechnol J. 2022 Aug 4;20:4415-4436. doi: 10.1016/j.csbj.2022.08.001. eCollection 2022. Comput Struct Biotechnol J. 2022. PMID: 36051878 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials